Gregory K. Hayer,Brendan Magrab,Henry R. Wolfe, JR.
申请号：
US15487735
公开号：
US20170216388A1
申请日:
2017.04.14
申请国别(地区):
US
年份:
2017
代理人:
摘要：
An oral dosage form or plurality of oral dosage forms comprising as active ingredients combinations of citric acid, magnesium citrate, phytin, pyridoxine, and musa is disclosed. The oral dosage form(s) is useful for inhibiting calcium oxalate crystal growth and for treating or inhibiting growth of kidney stones. Methods of inhibiting calcium oxalate crystal growth and of treating or preventing kidney stones are also disclosed.
